BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Memento EPFL//
BEGIN:VEVENT
SUMMARY:Redesigning the pharmaceutical R&D landscape for the post-COVID-19
  economy: the case of neglected diseases
DTSTART:20210630T170000
DTEND:20210630T180000
DTSTAMP:20260407T113440Z
UID:7be260507f063111fbc11b5fe64cdf00b456d47d458dd8cc7677c9f9
CATEGORIES:Conferences - Seminars
DESCRIPTION:Annamaria Conti\, Patrick Gaulé\, Tom Vogl\nThrough this Sem
 inar Series\, our academic community shares its research\, brainstorms an
 d identifies trends and challenges in different fields.\n\nDiseases that 
 primarily affect the developing world (such as malaria and other tropical 
 diseases) have long received comparatively little R&D investment. Hosted b
 y Annamaria Conti(UNIL-HEC)\, Patrick Gaulé (University of Bath) will 
 present new insights on why such diseases are neglected and which gaps in 
 the drug development pipeline could be targeted by policymakers. Tom Vogl
  (University of California\, San Diego) will discuss the implications of 
 the findings from a development economics perspective.\n 
LOCATION:https://epfl.zoom.us/meeting/register/u5crduqqqT0jEtX07AGUvLAMjfv
 PK1fX4JPb
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR